1950-39-6 Usage
Description
N'-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxysuccinamide monohydrochloride is a complex organic compound that features a variety of functional groups such as amines, hydroxyls, and carboxylic acids. It is a succinimide derivative with a hydrochloride salt, which may contribute to its potential in medicinal chemistry for the development of pharmaceuticals. N'-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxysuccinamide monohydrochloride's structural complexity and functional diversity allow it to form various chemical bonds with biological targets, making it a promising candidate for further research and application in the medical field.
Uses
Used in Pharmaceutical Development:
N'-[5-[[4-[[5-(acetylhydroamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxysuccinamide monohydrochloride is used as a building block for the synthesis of new pharmaceuticals due to its ability to form multiple chemical bonds with biological targets, which can enhance the compound's interaction with specific receptors or enzymes in the body.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, this compound serves as a subject of study for understanding its specific properties, such as its reactivity, stability, and potential interactions with biological systems. This research can lead to insights that inform the design of more effective drugs.
Used in Drug Delivery Systems:
N'-[5-[[4-[[5-(acetylhydroamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxysuccinamide monohydrochloride may be utilized in the development of drug delivery systems to improve the bioavailability and targeting of therapeutic agents, taking advantage of its functional groups to facilitate attachment to drug carriers or to enhance the compound's solubility and stability.
Used in Biochemical Assays and Diagnostics:
N'-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxysuccinamide monohydrochloride's reactivity and functional groups may also find applications in biochemical assays and diagnostic tools, where it could be used to detect or measure the presence of specific biological molecules, leveraging its ability to form stable bonds with target analytes.
Check Digit Verification of cas no
The CAS Registry Mumber 1950-39-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,9,5 and 0 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1950-39:
(6*1)+(5*9)+(4*5)+(3*0)+(2*3)+(1*9)=86
86 % 10 = 6
So 1950-39-6 is a valid CAS Registry Number.
1950-39-6Relevant articles and documents
Multistage process for the preparation of highly pure deferoxamine mesylate salt
-
, (2008/06/13)
The present invention provides a purification process whereby deferoxamine B produced by a microorganism and in mixture with other polyhydroxamates produced by the microorganism may be converted into its mesylate salt substantially free of the other polyhydroxamates and substantially free of chloride ion. The process includes adsorption and desorption of the deferoxamine B on an adsorption resin, direct precipitation of the deferoxamine free base out of the eluent from the adsorption resin, contacting of the deferoxamine B free base with methanesulfonic acid and isolation of the deferoxamine B mesylate salt by precipitation. This process minimizes decomposition of deferoxamine B.
Method for the synthesis of desferrioxamine B and analogs thereof
-
, (2008/06/13)
Disclosed is a synthesis of desferrioxamine B and analogs and homologs thereof beginning with the generation of the O-protected N-(4-cyanobutyl)hydroxylamine which is acylated at the O-benzylhydroxylamine nitrogen with either succinic or acetic anhydride. The resulting half-acid amide or amide respectively, is subjected to a series of high yield condensations and reductions which provide desferrioxamine B in 45% overall yield. Finally, a desamino analog of desferrioxamine is prepared in order to demonstrate the synthetic utility of the scheme as applied to desferrioxamine derivatives.
